Our previous studies provided evidence that the VEGF-C/VEGFR-3 axis enhances cancer cell mobility and invasiveness, contributes to the promotion of cancer metastasis, and is closely correlated with clinical metastasis and survival in patients with lung cancer [11]. Here, FLT4 is linked to lung carcinoma.